Board of management & Advisors
Philippe is a MD, PhD, is an Hepato-Gastroenterologist, graduated from the medical school at the University Paris VII. He received his PhD in Human Molecular Genetics from the University Paris VII. Philippe served at several scientific and medical management positions in Pharmaceutical industry (Solvay Pharma, Hoffmann-LaRoche) and Biotechnology (Genset, ProteaBio, AzurRx). Philippe is the President and the Chief Scientific Officer of Eukarÿs. He is the inventor of several patents, among which those of the C3P3 system.
Guillaume is graduated from Mines ParisTech and the École Polytechnique, where he awarded the scientific prize in economics. His expertise is entirely devoted to technological innovation and its financing, itinialy as head of the Office for Innovation and Technology policies of the French Ministry of Economy and Finance, then as advisor in the cabinet of Emmanuel Macron, then Minister for Economic Affairs. After having contributed to the business development of a software unicorn, Guillaume became in 2017 CEO of Flaminem, a startup specialized in Big Data analysis and artificial intelligence. In 2019, he joined INRIA, the French national research institute in computer sciences, as deputy CEO.
Pierre, Ecole des Ponts et Chaussées, is an entrepreneur and historical investor in the company. Pierre held the Presidency of SORIF, the real estate subsidiary of the Vinci Group, of which he was the founder. He currently holds the Presidency of IDEVI (Paris). Pierre brings his strong entrepreneurial and negotiating experience with large groups.
Thierry is the attorney at law of Eukarÿs and a historical investor in the company. Thierry is graduated from the University of Paris II Panthéon-Assas, holds a DEA (now Masters) in Business Law, a Master’s Degree in Tax Management, a Master’s Degree in Common Market Law and a diploma from the Institute of Political Studies (Sciences-Po – EcoFi).
Patrice is an succesful entrepreneur, former elected representative of Essonne and historical investor in the company.
Fabrice, who is the representative of PPRS Ventures, is graduated from the Paris Institute of Political Studies and in Law from the University of Paris I Panthéon-Sorbonne. Member of SFAF, CEO of Eponyme Partners, director of BodyCap, Fabrice is the former President of PPRS, a company specialized in the development of therapeutics, diagnostics and medical devices in the neuroscience field.